title: Is there a "best" choice of second-line agent in the treatment of recurrent, potentially platinum-sensitive ovarian cancer?
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Cannistra
mesh_terms: D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010166:Palliative Care; D010984:Platinum / Q000627:therapeutic use
chemical_list: D010984:Platinum